Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vigabatrin associated retinal dysfunction in children with epilepsy.

R Koul1, A Chacko, A Ganesh

  • 1Department of Child Health, Division of Paediatric Neurology, Sultan Qaboos University Hospital, Al Khod, 123, Sultanate of Oman. rkoul@omantel.net

Archives of Disease in Childhood
|November 24, 2001
PubMed
Summary

Vigabatrin can cause vision problems in children with epilepsy. Regular eye exams and tests like electroretinography are recommended to monitor for these vigabatrin-induced eye changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The bitter aftertaste: Chronic pancreatitis and diabetes from codeine cough syrup.

Journal of postgraduate medicine·2025
Same author

The Influence of Coccygeal Dynamic Patterns in Ganglion Impar Block for the Treatment of Chronic Refractory Coccydynia.

Journal of orthopaedic case reports·2024
Same author

Orthopedic Skin Closure in South India: Sutures Versus Staples and Their Postoperative Outcomes.

Cureus·2024
Same author

Neurofilament heavy chain and chitinase 3-like 1 as markers for monitoring therapeutic response in multiple sclerosis.

Multiple sclerosis and related disorders·2024
Same author

Understanding physician preferences about combined thrombolysis and thrombectomy in patients with large vessel occlusion: An international cross-sectional survey.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2024
Same author

Association of parent-reported timing of first tooth emergence and ECC: a secondary analysis of a case-control study.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2024

Area of Science:

  • Ophthalmology
  • Neurology
  • Pediatrics

Background:

  • Vigabatrin is a medication used to treat seizures.
  • Recent studies indicate potential eye abnormalities in patients undergoing vigabatrin treatment.

Purpose of the Study:

  • To prospectively identify and document eye changes in children treated with vigabatrin for seizures.
  • To assess the incidence and nature of visual disturbances associated with vigabatrin therapy in pediatric epilepsy patients.

Main Methods:

  • A prospective study followed 29 children on vigabatrin for an average of 6.5 years.
  • Ophthalmic examinations were conducted before treatment initiation and every six months thereafter.
  • Visual evoked potentials (VEPs) were assessed, though electroretinography (ERG) and electro-oculography (EOG) were not consistently available.

Related Experiment Videos

Main Results:

  • Of 21 children meeting inclusion criteria, 19% developed eye changes including retinal pigmentation, hypopigmented spots, vascular sheathing, and optic atrophy.
  • Abnormal visual evoked potentials (VEPs) were observed in 16 children.
  • The mean vigabatrin dose was 55.8 mg/kg/day, with a mean therapy duration of 35.7 months.

Conclusions:

  • Vigabatrin treatment is associated with significant eye damage in pediatric patients.
  • Due to the inability of young children to report visual symptoms, regular ophthalmic monitoring is crucial.
  • Recommended follow-up includes 3-6 month ophthalmic check-ups, VEPs, and, if possible, ERG and EOG to detect early signs of vigabatrin-induced retinopathy.